SG Americas Securities LLC Purchases Shares of 11,742 Astrana Health, Inc. (NASDAQ:ASTH)

SG Americas Securities LLC acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,742 shares of the company’s stock, valued at approximately $680,000.

Separately, Central Pacific Bank Trust Division bought a new stake in Astrana Health during the third quarter worth about $160,000. 52.77% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Robert W. Baird raised their price target on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. BTIG Research lifted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Stifel Nicolaus upped their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 1st. KeyCorp started coverage on Astrana Health in a report on Friday. They set a “sector weight” rating for the company. Finally, Truist Financial upped their price objective on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $61.20.

Astrana Health Trading Down 1.3 %

Shares of ASTH stock opened at $56.23 on Monday. Astrana Health, Inc. has a 12-month low of $28.86 and a 12-month high of $61.51. The firm has a 50 day moving average price of $51.76 and a two-hundred day moving average price of $45.22. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $3.15 billion, a PE ratio of 42.60, a price-to-earnings-growth ratio of 2.20 and a beta of 1.21.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to the consensus estimate of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The firm’s quarterly revenue was up 39.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.28 EPS. As a group, analysts predict that Astrana Health, Inc. will post 1.33 earnings per share for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.